Particle Therapy Market by Cover Page

Particle Therapy Market by Types (Heavy Ion Therapy and Proton Therapy), Cancer Types (Head & Neck Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Pediatric Cancer, Brain & Spinal Cord Tumors, and Others), Products (Cyclotron and Synchrotron), Applications (Ambulatory Surgery Centers, Clinics, Hospitals, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030

  • Report ID: CG-4433
  • Author: Growth Market Reports
  • Rating: 4.9
  • Total Reviews: 3
  • No. Of Pages: 198
  • Format:
  • Pub. Date: Upcoming
  • Share:

The particle therapy market size was valued at USD 677 million in 2021 and is projected to reach USD 1200 million by 2030, expanding at a CAGR of around 8% during the forecast period, 2022 – 2030. The growth of the market is attributed to the rising cancer prevalence and low risk of treatment-induced diseases.


Particle Therapy Market by Summary

Radiotherapy that uses particles is known as particle treatment. Its beam frequency can be changed dependent on the thickness of the treatment spot, allowing the cancer patient to get a targeted dose of radiation. Particle therapy is a type of external beam radiation therapy used in cancer that is one of the most advanced in the world. Compared to traditional photon therapy, this method saves healthy radiation tissue. These particles have better physical intrinsic qualities, lowering the intake dose to about half of what a clinically appropriate target would be.

The COVID-19 pandemic had a negative impact on the medical device sector, especially particle treatment equipment. The particle therapy market is projected to be influenced by the temporary delay of several elective procedures as governments and organizations try to ensure that COVID-19 patients have access to resources. Several countries have issued recommendations on elective procedures in order to relieve pressure on the healthcare system. Despite the availability of particle therapy emergency services in nearly all centers, the number of emergency patients attending centers for treatment had decreased. Supply chains have been disrupted by closed manufacturing facilities as a result of lockdowns, and reduced clinical trial recruitment has hampered the overall growth of the particle theory market.

Market Trends, Drivers, Restraints, and Opportunities

  • Rising cases of several types of cancers is one of the primary factors driving the global particle treatment market.
  • Technological advancement in particle theory has helped manufacturers to produce more effective and regulated particle therapy systems, which is projected to fuel the market during the forecast period.
  • Compared to traditional photon therapy, particle therapy, particularly proton therapy, has a number of advantages such as more precisely targets tumors and cancer cells, this is expected to boost the market.
  • Particle theory decreases the danger of injury to healthy tissues and organs in the surrounding area, which is estimated to propel the market during the projected period.
  • High cost of particle therapy treatment for cancer is a major factor impeding the market growth.
  • Operating, staffing, maintenance, and construction expenditures for particle treatment facilities are high, which is anticipated to hamper the market growth.
  • Absence of clear sight of tumors and their distinction from normal healthy tissue act as one of the key challenges that can restrict the market growth in the coming years.
  • Increasing healthcare expenditure and rising economic development in emerging nations is expected to create lucrative opportunities for the market players.

Scope of the Report


The report on the global particle therapy market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Particle Therapy Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2021

Historic Data

2019–2020

Forecast Period

2022 – 2030

Segmentation

Types (Heavy Ion Therapy and Proton Therapy), Cancer Types (Head & Neck Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Pediatric Cancer, Brain & Spinal Cord Tumors, and Others), Products (Cyclotron and Synchrotron), and Applications (Ambulatory Surgery Centers, Clinics, Hospitals, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Sumitomo Heavy Industries, Ltd.; Mevion Medical Systems; Hitachi, Ltd; Varian Medical Systems, Inc.; IBA Worldwide; Provision Healthcare; ProTom International, Inc.; Optivus Proton Therapy, Inc.; and Danfysik A/S.

Market Segment Insights

The proton therapy segment accounted for a major market share in 2021

Based on types, the market is bifurcated into heavy ion therapy and proton therapy. The proton therapy segment accounted for a major market share in 2021. Growth of the segment is attributed to educed side effects, shorter treatment time, high degree of precision, and high dose of radiation as compare to photon theory.

The brain & spinal cord tumors segment held a major market share in 2021

On the basis of cancer types, the market is segregated into head & neck cancer, breast cancer, lung cancer, prostate cancer, pediatric cancer, brain & spinal cord tumors, and others. The brain & spinal cord tumors segment held a major market share in 2021 and is projected to expand at a high CAGR during the forecast period. When treating brain and other central nervous system tumors, it is crucial to keep radiation doses to a minimum. This includes the brain stem, spinal cord, and healthy brain tissue, all of which govern critical body systems.


Particle Therapy Market by Cancer Types

The cyclotron segment is estimated to grow at a rapid pace during the forecast period

In terms of products, the market is bifurcated into cyclotron and synchrotron. The cyclotron segment is estimated to grow at a rapid pace during the forecast period. Proton therapy, which uses a focused beam of protons directed to a tumor site to treat various cancers, relies heavily on the usage of cyclotrons. Proton beam therapy generates and accelerates protons to rate of speed of up to 60% the speed of light and energy of up to 250 million volt using specialized equipment, the most common of which are the cyclotrons.

The hospitals segment held a key market share in 2021

Based on applications, the market is segregated into ambulatory surgery centers, clinics, hospitals, and others. The hospitals segment held a key market share in 2021. The hospital segment is estimated to increase at a CAGR of around 8.9% during the forecast period. Proton therapy is accessible in a number of hospitals, many of which are established and sponsored by commercial companies.

Asia Pacific dominated the market in 2021

On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific dominated the market in 2021 and is projected to expand at a substantial rate during the forecast period. Asia Pacific is likely to offer considerable potential prospects for participants in the particle therapy market, due to rising healthcare expenditure and increasing measures to promote the use of innovative particle therapy technologies in the region.


Particle Therapy Market by Regions

Segments

The global particle therapy market has been segmented on the basis of

Types
  • Heavy Ion Therapy
  • Proton Therapy
Cancer Types
  • Head & Neck Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Pediatric Cancer
  • Brain & Spinal Cord Tumors
  • Others
Products
  • Cyclotron
  • Synchrotron
Applications
  • Ambulatory Surgery Centers
  • Clinics
  • Hospitals
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Sumitomo Heavy Industries, Ltd.
  • Mevion Medical Systems
  • Hitachi, Ltd
  • Varian Medical Systems, Inc.
  • IBA Worldwide
  • Provision Healthcare
  • ProTom International, Inc.
  • Optivus Proton Therapy, Inc.
  • Danfysik A/S

Competitive Landscape

Key players competing in the particle therapy market include Sumitomo Heavy Industries, Ltd.; Mevion Medical Systems; Hitachi, Ltd; Varian Medical Systems, Inc.; IBA Worldwide; Provision Healthcare; ProTom International, Inc.; Optivus Proton Therapy, Inc.; and Danfysik A/S. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,

  • In January 2019, Oncora Medica and Varian Medical Systems, Inc. have formed a collaboration. This financial collaboration aimed to hasten the development of software tools that would allow radiation oncologists to practice precision medicine.
  • In April 2021, Tractebel has partnered with IBA Worldwide. This collaboration is estimated to help IBA's customers with proton theory construction and design projects.
Particle Therapy Market by Key Players
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Particle Therapy Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Particle Therapy Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Particle Therapy Market - Supply Chain
  4.5. Global Particle Therapy Market Forecast
     4.5.1. Particle Therapy Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Particle Therapy Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Particle Therapy Market Absolute $ Opportunity
5. Global Particle Therapy Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Particle Therapy Market Size and Volume Forecast by Types
     5.3.1. Heavy Ion Therapy
     5.3.2. Proton Therapy
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Particle Therapy Market Analysis and Forecast by Applications
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Applications
     6.2.2. Y-o-Y Growth Projections by Applications
  6.3. Particle Therapy Market Size and Volume Forecast by Applications
     6.3.1. Ambulatory Surgery Centers
     6.3.2. Clinics
     6.3.3. Hospitals
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by Applications
  6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Particle Therapy Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Particle Therapy Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Particle Therapy Demand Share Forecast, 2019-2026
8. North America Particle Therapy Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Particle Therapy Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Particle Therapy Market Size and Volume Forecast by Types
     8.4.1. Heavy Ion Therapy
     8.4.2. Proton Therapy
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Particle Therapy Market Size and Volume Forecast by Applications
     8.7.1. Ambulatory Surgery Centers
     8.7.2. Clinics
     8.7.3. Hospitals
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by Applications
  8.9. Y-o-Y Growth Projections by Applications
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Particle Therapy Demand Share Forecast, 2019-2026
9. Latin America Particle Therapy Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Particle Therapy Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Particle Therapy Market Size and Volume Forecast by Types
     9.4.1. Heavy Ion Therapy
     9.4.2. Proton Therapy
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Particle Therapy Market Size and Volume Forecast by Applications
     9.7.1. Ambulatory Surgery Centers
     9.7.2. Clinics
     9.7.3. Hospitals
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by Applications
  9.9. Y-o-Y Growth Projections by Applications
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Particle Therapy Demand Share Forecast, 2019-2026
10. Europe Particle Therapy Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Particle Therapy Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Particle Therapy Market Size and Volume Forecast by Types
     10.4.1. Heavy Ion Therapy
     10.4.2. Proton Therapy
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Particle Therapy Market Size and Volume Forecast by Applications
     10.7.1. Ambulatory Surgery Centers
     10.7.2. Clinics
     10.7.3. Hospitals
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by Applications
  10.9. Y-o-Y Growth Projections by Applications
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Particle Therapy Demand Share Forecast, 2019-2026
11. Asia Pacific Particle Therapy Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Particle Therapy Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Particle Therapy Market Size and Volume Forecast by Types
     11.4.1. Heavy Ion Therapy
     11.4.2. Proton Therapy
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Particle Therapy Market Size and Volume Forecast by Applications
     11.7.1. Ambulatory Surgery Centers
     11.7.2. Clinics
     11.7.3. Hospitals
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by Applications
  11.9. Y-o-Y Growth Projections by Applications
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Particle Therapy Demand Share Forecast, 2019-2026
12. Middle East & Africa Particle Therapy Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Particle Therapy Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Particle Therapy Market Size and Volume Forecast by Types
     12.4.1. Heavy Ion Therapy
     12.4.2. Proton Therapy
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Particle Therapy Market Size and Volume Forecast by Applications
     12.7.1. Ambulatory Surgery Centers
     12.7.2. Clinics
     12.7.3. Hospitals
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by Applications
  12.9. Y-o-Y Growth Projections by Applications
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Particle Therapy Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Particle Therapy Market: Market Share Analysis
  13.2. Particle Therapy Distributors and Customers
  13.3. Particle Therapy Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Sumitomo Heavy Industries, Ltd.
     13.4.2. Mevion Medical Systems
     13.4.3. Hitachi, Ltd
     13.4.4. Varian Medical Systems, Inc.
     13.4.5. IBA Worldwide
     13.4.6. Provision Healthcare
     13.4.7. ProTom International, Inc.
     13.4.8. Optiv

The global particle therapy market has been segmented on the basis of

Types
  • Heavy Ion Therapy
  • Proton Therapy
Cancer Types
  • Head & Neck Cancer
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Pediatric Cancer
  • Brain & Spinal Cord Tumors
  • Others
Products
  • Cyclotron
  • Synchrotron
Applications
  • Ambulatory Surgery Centers
  • Clinics
  • Hospitals
  • Others
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Sumitomo Heavy Industries, Ltd.
  • Mevion Medical Systems
  • Hitachi, Ltd
  • Varian Medical Systems, Inc.
  • IBA Worldwide
  • Provision Healthcare
  • ProTom International, Inc.
  • Optivus Proton Therapy, Inc.
  • Danfysik A/S

Key players competing in the particle therapy market include Sumitomo Heavy Industries, Ltd.; Mevion Medical Systems; Hitachi, Ltd; Varian Medical Systems, Inc.; IBA Worldwide; Provision Healthcare; ProTom International, Inc.; Optivus Proton Therapy, Inc.; and Danfysik A/S. Some of these players are using several market strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares, generate revenue, and raise their production line of the business in the coming years. For instance,

  • In January 2019, Oncora Medica and Varian Medical Systems, Inc. have formed a collaboration. This financial collaboration aimed to hasten the development of software tools that would allow radiation oncologists to practice precision medicine.
  • In April 2021, Tractebel has partnered with IBA Worldwide. This collaboration is estimated to help IBA's customers with proton theory construction and design projects.
Particle Therapy Market by Key Players

Buy Report

FAQ Section

Some frequently asked quetions about this report!

The cyclotron segment is estimated to grow at a rapid pace during the forecast period.

The particle therapy market is projected expand at a CAGR of around 8% during the forecast period, 2022 – 2030.

Operating, staffing, maintenance, and construction expenditures for particle treatment facilities are high, which is anticipated to hinder the market growth.

Asia Pacific dominated the market in 2021.

ProTom International, Inc.; Optivus Proton Therapy, Inc.; and Danfysik A/S are some of the top players in the market.